These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 7473681

  • 21. Use of the BACTEC system for drug susceptibility testing of Mycobacterium tuberculosis, M. kansasii, and M. avium complex.
    Steadham JE, Stall SK, Simmank JL.
    Diagn Microbiol Infect Dis; 1985 Jan; 3(1):33-40. PubMed ID: 3917885
    [Abstract] [Full Text] [Related]

  • 22. Susceptibility of Oral Streptococci to Chlorhexidine and Cetylpyridinium Chloride.
    So Yeon L, Si Young L.
    Biocontrol Sci; 2019 Jan; 24(1):13-21. PubMed ID: 30880309
    [Abstract] [Full Text] [Related]

  • 23. [Susceptibility of various mycobacteria to ethambutol--with reference to the differentiation between M. avium and M. terrae].
    Mizuno S, Toyama H, Tsukamura M.
    Nihon Saikingaku Zasshi; 1966 Nov; 21(11):672-4. PubMed ID: 6010588
    [No Abstract] [Full Text] [Related]

  • 24. In vitro drug sensitivity of M. avium-intracellulare complex in the presence and absence of dimethyl sulphoxide.
    Nash DR, Steingrube VA.
    Microbios; 1982 Nov; 35(140):71-8. PubMed ID: 7162431
    [Abstract] [Full Text] [Related]

  • 25. Reduced susceptibility of methicillin-resistant Staphylococcus aureus to cetylpyridinium chloride and chlorhexidine.
    Irizarry L, Merlin T, Rupp J, Griffith J.
    Chemotherapy; 1996 Nov; 42(4):248-52. PubMed ID: 8804791
    [Abstract] [Full Text] [Related]

  • 26. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y, Cabral C, Shapiro DS, McGrath P.
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [Abstract] [Full Text] [Related]

  • 27. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T, Drlica K.
    J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
    [Abstract] [Full Text] [Related]

  • 28. [In vitro bacteriocidal activity of 5 oral antiseptics against the principal microorganisms implicated in oral disease].
    Luc J, Roques C, Frayret MN, Michel G, Ducani M, Vandermander J.
    J Parodontol; 1991 Nov; 10(4):381-7. PubMed ID: 1811047
    [Abstract] [Full Text] [Related]

  • 29. [Correlation of minimal inhibitory concentration values of antituberculosis agents against Mycobacterium avium complex strains with incubation period].
    Tsukamura M, Ichiyama S.
    Kekkaku; 1988 Feb; 63(2):107-10. PubMed ID: 3373933
    [No Abstract] [Full Text] [Related]

  • 30. Combined vs. single-drug studies of susceptibilities of Mycobacterium kansasii to isoniazid, streptomycin, and ethambutol.
    Tsang AY, Bentz RR, Schork MA, Sodeman TM.
    Am J Clin Pathol; 1978 Nov; 70(5):816-20. PubMed ID: 717288
    [Abstract] [Full Text] [Related]

  • 31. Outer membrane changes in Pseudomonas stutzeri resistant to chlorhexidine diacetate and cetylpyridinium chloride.
    Tattawasart U, Maillard JY, Furr JR, Russell AD.
    Int J Antimicrob Agents; 2000 Nov; 16(3):233-8. PubMed ID: 11091041
    [Abstract] [Full Text] [Related]

  • 32. Two groups of Mycobacterium avium complex strains determined according to the susceptibility to rifampicin and ansamycin.
    Tsukamura M.
    Microbiol Immunol; 1987 Nov; 31(7):615-23. PubMed ID: 3125413
    [Abstract] [Full Text] [Related]

  • 33. Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis.
    Taneja NK, Tyagi JS.
    J Antimicrob Chemother; 2007 Aug; 60(2):288-93. PubMed ID: 17586560
    [Abstract] [Full Text] [Related]

  • 34. [Sensitivity of M. tuberculosis and atypical mycobacteria to ethambutol, capreomycin and rifampicin].
    Schröder KH, Hensel J, Scheuch V.
    Prax Pneumol; 1969 Oct; 23(10):683-94. PubMed ID: 4984409
    [No Abstract] [Full Text] [Related]

  • 35. [The effect of emetine hydrochloride on the growth of different mycobacteria strains].
    Schwartz E.
    Zentralbl Bakteriol Orig; 1969 Dec; 212(1):115-25. PubMed ID: 4989350
    [No Abstract] [Full Text] [Related]

  • 36. Efficacy of macrolides used in combination with ethambutol, with or without other drugs, against Mycobacterium avium within human macrophages.
    Schiavano GF, Celeste AG, Salvaggio L, Sisti M, Brandi G.
    Int J Antimicrob Agents; 2001 Dec; 18(6):525-30. PubMed ID: 11738339
    [Abstract] [Full Text] [Related]

  • 37. [Extracellular and intracellular activity of sparfloxacin against Mycobacterium avium complex and Mycobacterium xenopi].
    Gevaudan MJ, Bollet C, Mallet MN, de Lamballerie X, Sambuc R, de Micco P.
    Pathol Biol (Paris); 1992 May; 40(5):443-9. PubMed ID: 1323093
    [Abstract] [Full Text] [Related]

  • 38. Susceptibilities of Actinobacillus actinomycetemcomitans biofilms to oral antiseptics.
    Thrower Y, Pinney RJ, Wilson M.
    J Med Microbiol; 1997 May; 46(5):425-9. PubMed ID: 9152040
    [Abstract] [Full Text] [Related]

  • 39. Combinations of rifampin or rifabutine plus ethambutol against Mycobacterium avium complex. Bactericidal synergistic, and bacteriostatic additive or synergistic effects.
    Heifets LB, Iseman MD, Lindholm-Levy PJ.
    Am Rev Respir Dis; 1988 Mar; 137(3):711-5. PubMed ID: 2830814
    [Abstract] [Full Text] [Related]

  • 40. Biological evaluation of bisbenzaldehydes against four Mycobacterium species.
    Cappoen D, Forge D, Vercammen F, Mathys V, Kiass M, Roupie V, Anthonissen R, Verschaeve L, Vanden Eynde JJ, Huygen K.
    Eur J Med Chem; 2013 May; 63():731-8. PubMed ID: 23567963
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.